A Randomized, Double-blind, Multi-center, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel (DSG) 1% Applied Four Times Daily in Subjects With Acute Blunt Soft Tissue Injuries/Contusions of the Limbs.

Trial Profile

A Randomized, Double-blind, Multi-center, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel (DSG) 1% Applied Four Times Daily in Subjects With Acute Blunt Soft Tissue Injuries/Contusions of the Limbs.

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Jan 2013

At a glance

  • Drugs Diclofenac (Primary)
  • Indications Musculoskeletal pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Apr 2012 New source identified and integrated (European Clinical Trials Database: EudraCT2010-020936-21).
    • 18 Apr 2012 Actual patient number 204 added as reported by ClinicalTrials.gov.
    • 29 Jul 2011 Actual end date (Jul 2011) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top